A Longitudinal Survey Study on Living With Sickle Cell Disease in the COVID-19 Pandemic

About the study

Background:

Sickle cell disease (SCD) is a chronic illness. It affects about 100,000 people in the United States. People with SCD have red blood cells that are sickle-shaped and impaired in their function. This results in a lifetime of complications that affect every organ system. People with SCD also are at greater risk for respiratory infections and lung problems. Researchers want to study how this population s stress, anxiety, fear, pain, sleep, and health care use are being affected by the COVID-19 pandemic.

Objective:

To study the extent and impact of life changes induced by the COVID-19 pandemic on people living with SCD in the U.S.

Eligibility:

People age 18 and older with SCD who live in the U.S.

Design:

Participants will complete a survey online. The questions will focus on the following:

Medical history

Mental and physical health

Demographics

Stress

Resilience

Health care use

COVID-19

Beliefs about medical mistrust and participation in research.

At the end of the survey, participants will be asked if they would like to take the survey again in the future. If they reply “yes,” then they will be contacted by the study team in 6-9 months to take the survey again. They may complete the survey again in 6-8 months, 12-15 months, and 18-21 months.

The survey should take less than 40 minutes to complete.

Participants’ data will be coded to protect their privacy. The coded data may be shared with other researchers.

Study point of contact

Vence L Bonham, J.D.
(301) 594-3973
[email protected]
Hasmin C Ramirez
(301) 435-6817
[email protected]

Locations

1 United States site

Age

> 18 Years

Study type

Observational

Age

18 Years -

Gender

All

Compensation

Unknown

participation requirements

In order to be eligible to participate in this study, an individual must meet all of the following criteria:

Stated willingness to comply with all study procedures and availability for the duration of the study
Adults, aged 18 years or older, of any race, sex, gender, ethnicity, and/or nationality
Sickle Cell Disease, any genotype
Current Resident of the United States

participation restrictions

An individual who meets any of the following criteria will be excluded from participation in this study:

Minors less than 18 years of age
Adults with Sickle Cell Trait, Beta Thalassemia, Alpha Thalassemia or any blood disorder other than Sickle Cell Disorder
Adults who lack access to the Internet
Live outside the United States (unless they are from the INSIGHTS Study)

Locations

  • Bethesda, Maryland, United States, National Human Genome Research Institute (NHGRI), 20892 [Recruiting]
Last updated 2022-05-18